Shilanski & Associates’s Crocs CROX Stock Holding History

Shilanski & Associates’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,036	Closed	-$1.24M	–	105
2023 Q2	$1.24M	Buy	+11,036	New	+$1.32M	0.5%	52

Other funds holding CROX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BPIH

Broad Peak Investment Holdings Singapore $531M AUM 24.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Shilanski & Associates's CROX Position: Q3 2023 in Review

Shilanski & Associates sold out of Crocs (CROX) in Q3 2023, closing a stake of 11,036 shares — an estimated $1.24M sold.

Shilanski & Associates first reported a position in CROX in Q2 2023 and held it in 1 quarter. The position peaked at $1.24M in Q2 2023. 431 funds tracked by Wall St. Rank hold CROX as of Q3 2023.

Shilanski & Associates reported no remaining Crocs position as of Q3 2023 after selling out during the quarter.
Shilanski & Associates sold 11,036 Crocs shares in Q3 2023, an estimated $1.24M.
Shilanski & Associates first reported a position in Crocs in Q2 2023 and held it in 1 quarter.
Shilanski & Associates's Crocs position peaked at $1.24M in Q2 2023.
431 funds tracked by Wall St. Rank held Crocs as of Q3 2023.

Based on Shilanski & Associates's 13F filing for Q3 2023, filed 14 Nov 2023.